Viral Disease Stocks List

Recent Signals

Date Stock Signal Type
2021-04-09 ALVR NR7-2 Range Contraction
2021-04-09 ALVR NR7 Range Contraction
2021-04-09 EVAX Pocket Pivot Bullish Swing Setup
2021-04-09 HOOK 20 DMA Support Bullish
2021-04-09 NNVC Crossed Above 200 DMA Bullish
2021-04-09 PRVB Volume Surge Other
2021-04-09 PRVB New 52 Week Low Weakness
2021-04-09 PRVB Wide Range Bar Range Expansion
2021-04-09 PRVB New 52 Week Closing Low Bearish
2021-04-09 PRVB Gilligan's Island Buy Setup Bullish Swing Setup
2021-04-09 PRVB Expansion Breakdown Bearish Swing Setup
2021-04-09 TRIB NR7-2 Range Contraction
2021-04-09 TRIB NR7 Range Contraction
2021-04-09 TRIB Narrow Range Bar Range Contraction
2021-04-09 VIVO 50 DMA Support Bullish
2021-04-09 VIVO Stochastic Reached Oversold Weakness
2021-04-09 VIVO Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-04-09 VIVO Fell Below 20 DMA Bearish

Recent News for Viral Disease Stocks

Date Stock Title
Apr 10 PRVB The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
Apr 10 HOOK HOOKIPA announces positive preliminary Phase 1 immunogenicity data for its immunotherapy candidates to treat advanced HPV16+ cancers
Apr 9 PRVB Provention Bio: Oversold Territory, An Attractive Buying Opportunity
Apr 9 VIVO Meridian Bioscience: Good Stock, But Margin Of Safety Required
Apr 9 PRVB Mid-Afternoon Market Update: Dow Surges Over 100 Points; Provention Bio Shares Plunge
Apr 9 PRVB Provention Bio shares struggle after FDA feedback on teplizumab BLA, analyst downgrades
Apr 9 PRVB What's Going On With CELC Stock And PRVB Stock Today?
Apr 9 PRVB Provention Bio downgraded on FDA feedback, Citi sizes up Zuranolone success on Sage, and more in today’s analyst action
Apr 9 PRVB Provention Drops as FDA Identifies Deficiencies in Drug Application
Apr 9 PRVB Provention Bio Shares Crash 40% Due To Regulatory Setback For Diabetes Drug
Apr 9 PRVB The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
Apr 9 PRVB Provention Bio Stock Craters After FDA Flags Deficiencies In PK Profiles From Teplizumab Trials For Diabetes
Apr 8 PRVB Provention Bio gives update on teplizumab BLA, FDA feedback
Apr 8 PRVB Provention Bio Provides Regulatory Update on Biologics License Application for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-Risk Individuals
Apr 8 ALVR Analysts Say These 3 Stocks Are Their Top Picks for 2021
Apr 6 EVAX Evaxion Biotech ADS EPS misses by $0.02
Apr 6 EVAX Evaxion Biotech Announces Q4 and Full-Year 2020 Financial Results and Provides Business Update
Apr 6 EVAX Earnings Scheduled For April 6, 2021
Apr 5 VIVO The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Hill-Rom Holdings, Owens & Minor, McKesson Corp and Meridian Bioscience